Archive for the 'MRI / PET / Ultrasound' Category


Tomophase OCTIS(TM) Receives FDA 510(K) Clearance To Market

Tomophase Corporation, developer of the non-invasive Optical Coherence Tomography Imaging System (OCTIS™) and other devices, announced that it has received FDA 510(k) clearance to market OCTIS. Tomophase is a leader in the development of OCT brochoscopically-based imaging systems for interventional pulmonology…


(more...)


United Hayek Set To Radically Change The MRI Landscape; Much Cheaper MRI Scans To Come

United Hayek Industries announced the release of a new device, The Hayek MRI-RTX, making MRI scans significantly cheaper using synchronized respiratory and cardiac motion. The new device allows coronary MRAs to be performed in half the scan time with higher navigator efficiency. This will allow many people to undergo MRA Imaging at a significantly reduced cost, and allow insurance companies to screen insurance candidates very cost effectively.
(more...)


Pulmo BioTech Inc. Announces Paper To Be Presented At Symposium

Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PLO) has announced that Dr. Jocelyn Dupuis, the Chief Scientific Officer of its Pulmo Science Inc. subsidiary and the originator of the PulmoBind concept is to present a paper at the 5th International Symposium on Peptide Receptors and Kinin 2009 to be held in Quebec, Canada from June 26th to 29th.
(more...)


UQ Breaks New Ground In Human MRI Technology

In a scientific development set to benefit sufferers of respiratory diseases, a UQ research team has pioneered Australian-first imaging technology. A group of UQ scientists, from the Centre for Magnetic Resonance and the Department of Physics, have successfully developed Australia's first hyperpolarised helium gas for use in human MRIs.
(more...)


Human Applications For Novel Veterinary Procedure Detecting Life-Threatening Injuries

The incidence of pneumothorax (PTX), or collapsed lung, among dogs and cats with blunt and penetrating trauma has been reported to range from 13 - 50 percent, with mortality rates ranging from 10 - 18 percent. In people, PTX is reported to be the most preventable cause of death in trauma patients. Thoracic ultrasound has been infrequently used as a non-invasive, point-of-care imaging technique to detect PTX and other thoracic injuries in veterinary trauma patients.
(more...)